Published in Hematology Week, November 16th, 2009
The researchers hope that their discovery will lead to the development of a new class of drugs to treat the condition, known as hyperkalemia, which is caused when patients can't properly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2009-11-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.